Colinz Laboratories Ltd.

Financial

	Colinz Laboratories	Unjha Formulations	Beryl Drugs
Operational Metrics
Financials
5 yr Average ROE	4.05 %	10.34 %	2.54 %
5yr average Equity Multiplier	1.3	1.62	2.23
5yr Average Asset Turnover Ratio	0.7	3.51	1.08
5yr Avg Net Profit Margin	4.66 %	1.88 %	0.66 %
Price to Book	1.16	3.5	1.16
P/E	22.94	27.62	18.39
5yr Avg Cash Conversion Cycle	-0.66 Days	18.8 Days	-619.24 Days
Inventory Days	64.79 Days	28.57 Days	36.1 Days
Days Receivable	51.75 Days	41.04 Days	98.89 Days
Days Payable	78.66 Days	53.92 Days	969.29 Days
5yr Average Interest Coverage Ratio	9.16	17.56	1.68
5yr Avg ROCE	6.01 %	19.44 %	5.73 %
5yr Avg Operating Profit Margin	6.82 %	3.19 %	7.19 %
5 yr average Debt to Equity	0.07	0.0	0.64
5yr CAGR Net Profit	30.39 %	32.6 %	72.78 %
5yr Average Return on Assets	3.14 %	6.62 %	1.31 %
Shareholdings
Promoter Holding	66.0 %	36.92 %	26.38 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.01 %	0.0	1.46 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0